Cutler Group LP Sorrento Therapeutics, Inc. Call Options Transaction History

Cutler Group LP

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Oct 25, 2022	SELL	$1.51 - $2.88 $2,416 - $4,608	-1,600 Reduced 15.53%	8,700 $0
Q2 2022 Aug 04, 2022	SELL	$1.24 - $2.33 $8,928 - $16,776	-7,200 Reduced 41.14%	10,300 $0
Q1 2022 Apr 14, 2022	BUY	$2.0 - $4.9 $31,600 - $77,420	15,800 Added 929.41%	17,500 $2,000
Q2 2021 Jul 19, 2021	SELL	$6.35 - $10.0 $2,540 - $4,000	-400 Reduced 19.05%	1,700 $2,000
Q1 2021 Apr 26, 2021	SELL	$7.03 - $16.51 $113,183 - $265,811	-16,100 Reduced 88.46%	2,100 $4,000
Q4 2020 Jan 21, 2021	SELL	$5.76 - $11.95 $611,712 - $1.27 Million	-106,200 Reduced 85.37%	18,200 $13,000
Q3 2020 Oct 27, 2020	BUY	$6.17 - $18.82 $481,260 - $1.47 Million	78,000 Added 168.1%	124,400 $342,000
Q2 2020 Jul 22, 2020	BUY	$1.73 - $6.76 $79,234 - $309,608	45,800 Added 7633.33%	46,400 $82,000
Q4 2019 Feb 06, 2020	BUY	$1.45 - $4.17 $870 - $2,502	600 New	600 $0
Q4 2018 Feb 05, 2019	SELL	$2.01 - $4.24 $401 - $848	-200 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$4.22 - $7.5 $844 - $1,500	200 New	200 $0

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.